HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements.

Abstract
IT-101, a cyclodextrin polymer-based nanoparticle containing camptothecin, is in clinical development for the treatment of cancer. Multiorgan pharmacokinetics and accumulation in tumor tissue of IT-101 is investigated by using PET. IT-101 is modified through the attachment of a 1,4,7,10-tetraazacyclododecane-1,4,7-Tris-acetic acid ligand to bind (64)Cu(2+). This modification does not affect the particle size and minimally affects the surface charge of the resulting nanoparticles. PET data from (64)Cu-labeled IT-101 are used to quantify the in vivo biodistribution in mice bearing Neuro2A s.c. tumors. The (64)Cu-labeled IT-101 displays a biphasic plasma elimination. Approximately 8% of the injected dose is rapidly cleared as a low-molecular-weight fraction through the kidneys. The remaining material circulates in plasma with a terminal half-life of 13.3 h. Steadily increasing concentrations, up to 11% injected dose per cm(3), are observed in the tumor over 24 h, higher than any other tissue at that time. A 3-compartment model is used to determine vascular permeability and nanoparticle retention in tumors, and is able to accurately represent the experimental data. The calculated tumor vascular permeability indicates that the majority of nanoparticles stay intact in circulation and do not disassemble into individual polymer strands. A key assumption to modeling the tumor dynamics is that there is a "sink" for the nanoparticles within the tumor. Histological measurements using confocal microscopy show that IT-101 localizes within tumor cells and provides the sink in the tumor for the nanoparticles.
AuthorsThomas Schluep, Jungyeon Hwang, Isabel J Hildebrandt, Johannes Czernin, Chung Hang J Choi, Christopher A Alabi, Brendan C Mack, Mark E Davis
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 106 Issue 27 Pg. 11394-9 (Jul 07 2009) ISSN: 1091-6490 [Electronic] United States
PMID19564622 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cyclodextrins
  • IT-101
  • Polymers
  • Copper
  • Camptothecin
Topics
  • Animals
  • Camptothecin (pharmacokinetics)
  • Cell Line, Tumor
  • Copper (pharmacokinetics)
  • Cyclodextrins (pharmacokinetics)
  • Fluorescent Antibody Technique
  • Kidney (metabolism)
  • Mice
  • Mice, SCID
  • Models, Biological
  • Nanoparticles
  • Neoplasms (pathology)
  • Polymers (pharmacokinetics)
  • Positron-Emission Tomography
  • Tissue Distribution
  • Whole Body Imaging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: